{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:47:46Z","timestamp":1791924466140,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032718","name":"Kura Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014620","name":"Micropalaeontological Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030732","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmorwd.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Real World Data and Digital Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.esmorw.2026.100788","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:44:30Z","timestamp":1791823470000},"page":"100788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["HeCOG Cancer Biobank and Registry: a nationwide real-world resource for translational oncology research"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4884-2544","authenticated-orcid":false,"given":"E.","family":"Fountzilas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0389-4209","authenticated-orcid":false,"given":"K.","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.-A.","family":"Koliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4219-3130","authenticated-orcid":false,"given":"T.","family":"Papapavlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pectasides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Samantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bafaloukos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Aravantinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Kosmidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.P.","family":"Kalofonos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sgouros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Papakostas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3873-2947","authenticated-orcid":false,"given":"E.","family":"Razis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Economopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Zamboglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Koutras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6632-2462","authenticated-orcid":false,"given":"G.","family":"Pentheroudakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7153-6556","authenticated-orcid":false,"given":"F.","family":"Zagouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Linardou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Christopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Papamichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4913-3097","authenticated-orcid":false,"given":"P.","family":"Skarlos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4353-9535","authenticated-orcid":false,"given":"A.","family":"Batistatou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Goussia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7600-6973","authenticated-orcid":false,"given":"H.P.","family":"Kourea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pervana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Tzaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Petraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Pavlakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Arapantoni-Dadioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Koletsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Kotoula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Pavlidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0451-2885","authenticated-orcid":false,"given":"H.","family":"Gogas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Psyrri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8045-2186","authenticated-orcid":false,"given":"G.","family":"Fountzilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.esmorw.2026.100788_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1385\/MO:21:2:095","article-title":"Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer: a Hellenic Cooperative Oncology Group Phase III Study","volume":"21","author":"Fountzilas","year":"2004","journal-title":"Med Oncol"},{"issue":"6","key":"10.1016\/j.esmorw.2026.100788_bib2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1200\/JCO.2008.16.3121","article-title":"Randomized phase III study of 1 month versus 1 year of adjuvant high-dose interferon alfa-2b in patients with resected high-risk melanoma","volume":"27","author":"Pectasides","year":"2009","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.esmorw.2026.100788_bib3","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1200\/JCO.2002.12.112","article-title":"Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial","volume":"20","author":"Kosmidis","year":"2002","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.esmorw.2026.100788_bib4","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1023\/A:1012295131640","article-title":"Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)","volume":"12","author":"Skarlos","year":"2001","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.esmorw.2026.100788_bib5","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/annonc\/mdi366","article-title":"Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group","volume":"16","author":"Fountzilas","year":"2005","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.esmorw.2026.100788_bib6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10549-011-1913-4","article-title":"Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10\/00 phase III Trial","volume":"132","author":"Gogas","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.esmorw.2026.100788_bib7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41416-022-01846-y","article-title":"Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10\/05 Trial","volume":"127","author":"Zagouri","year":"2022","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.esmorw.2026.100788_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/annonc\/mdr116","volume":"23","author":"Fountzilas","year":"2012","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.esmorw.2026.100788_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10549-008-0047-9","article-title":"A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study","volume":"115","author":"Fountzilas","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.esmorw.2026.100788_bib10","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1158\/2767-9764.CRC-23-0051","article-title":"Phase II window study of olaparib alone or with cisplatin or durvalumab in operable head and neck cancer","volume":"3","author":"Moutafi","year":"2023","journal-title":"Cancer Res Commun"},{"key":"10.1016\/j.esmorw.2026.100788_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115660","article-title":"Intercalated Avelumab plus platinum-based chemotherapy in patients with Extensive-Stage Small-Cell Lung cancer (PAVE): final outcome, immunophenotypic and biomarker analysis of a multi-center phase II Hellenic Cooperative Oncology Group study","volume":"228","author":"Linardou","year":"2025","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.esmorw.2026.100788_bib12","article-title":"Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer (A-REPEAT study): efficacy and correlations with tissue and plasma genotyping","volume":"7","author":"Sgouros","year":"2025","journal-title":"ESMO Gastrointest Oncol"},{"key":"10.1016\/j.esmorw.2026.100788_bib13","series-title":"Protection of individuals with regard to the processing of personal data and on the free movement of such data","year":"1997"},{"key":"10.1016\/j.esmorw.2026.100788_bib14","first-page":"31","article-title":"Directive 95\/46\/EC of the European Parliament and of the Council of 24 October 1995","volume":"L281","year":"1995","journal-title":"Official Journal of the European Communities"},{"key":"10.1016\/j.esmorw.2026.100788_bib15","series-title":"WMA Declaration of Helsinki\u2013Ethical Principles for Medical Research Involving Human Participants","year":"2024"},{"key":"10.1016\/j.esmorw.2026.100788_bib16","series-title":"Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine (Oviedo Convention)","year":"1997"},{"key":"10.1016\/j.esmorw.2026.100788_bib17","series-title":"Ratification of the Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine","year":"1998"},{"issue":"1","key":"10.1016\/j.esmorw.2026.100788_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2016.18","article-title":"The FAIR Guiding Principles for scientific data management and stewardship","volume":"3","author":"Wilkinson","year":"2016","journal-title":"Sci Data"},{"issue":"15","key":"10.1016\/j.esmorw.2026.100788_bib19","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.3390\/cancers17152543","article-title":"Real-world toxicity and effectiveness study of abemaciclib in Greek patients with hormone receptor-positive\/human epidermal growth factor receptor 2-negative breast cancer: a multi-institutional study","volume":"17","author":"Fountzilas","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.esmorw.2026.100788_bib20","article-title":"Real-world safety and effectiveness data of trastuzumab deruxtecan and sacituzumab govitecan in breast cancer: a Hellenic Cooperative Oncology Group study","volume":"7","author":"Fountzilas","year":"2025","journal-title":"ESMO Real World Data Digit Oncol"},{"key":"10.1016\/j.esmorw.2026.100788_bib21","article-title":"Real-world efficacy and toxicity data of paclitaxel and ramucirumab compared with other treatment regimens in patients with advanced gastric cancer","volume":"5","author":"Fountzilas","year":"2024","journal-title":"ESMO Gastrointest Oncol"},{"issue":"11","key":"10.1016\/j.esmorw.2026.100788_bib22","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/diagnostics14111076","article-title":"Nationwide real-world data of microsatellite instability and\/or mismatch repair deficiency in cancer: prevalence and testing patterns","volume":"14","author":"Fountzilas","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"10.1016\/j.esmorw.2026.100788_bib23","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.21873\/anticanres.16449","article-title":"Real-world data and economic evaluation of nivolumab in previously treated non-small cell lung cancer Greek patients","volume":"43","author":"Linardou","year":"2023","journal-title":"Anticancer Res"},{"key":"10.1016\/j.esmorw.2026.100788_bib24","first-page":"93","volume":"12","author":"Mountzios","year":"2021","journal-title":"Lung Cancer (Auckl)"},{"issue":"2","key":"10.1016\/j.esmorw.2026.100788_bib25","first-page":"327","article-title":"Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group","volume":"71","author":"Fountzilas","year":"2022","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"10.1016\/j.esmorw.2026.100788_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000774","volume":"5","author":"Fountzilas","year":"2020","journal-title":"ESMO Open"},{"issue":"suppl 9","key":"10.1016\/j.esmorw.2026.100788_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12920-019-0636-y","article-title":"Comparison of somatic variant detection algorithms using Ion Torrent targeted deep sequencing data","volume":"12","author":"Wang","year":"2019","journal-title":"BMC Med Genomics"},{"issue":"7","key":"10.1016\/j.esmorw.2026.100788_bib28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa053007","article-title":"Prognostic significance of autoimmunity during treatment of melanoma with interferon","volume":"354","author":"Gogas","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.esmorw.2026.100788_bib29","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/ng.3826","article-title":"Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer","volume":"49","author":"Phelan","year":"2017","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.esmorw.2026.100788_bib30","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/ng.985","article-title":"A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer","volume":"43","author":"Haiman","year":"2011","journal-title":"Nat Genet"},{"issue":"22","key":"10.1016\/j.esmorw.2026.100788_bib31","doi-asserted-by":"crossref","first-page":"32731","DOI":"10.18632\/oncotarget.9022","article-title":"TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting","volume":"7","author":"Fountzilas","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.esmorw.2026.100788_bib32","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1080\/10428190600709226","article-title":"Primary gastrointestinal non-Hodgkin\u2019s lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG)","volume":"47","author":"Papaxoinis","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.esmorw.2026.100788_bib33","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1158\/1078-0432.CCR-15-1543","article-title":"Evaluation of PD-L1 expression and associated tumor-infiltrating lymphocytes in laryngeal squamous cell carcinoma","volume":"22","author":"Vassilakopoulou","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"19","key":"10.1016\/j.esmorw.2026.100788_bib34","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1158\/0008-5472.CAN-11-1266","article-title":"Common breast cancer susceptibility loci are associated with triple-negative breast cancer","volume":"71","author":"Stevens","year":"2011","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.esmorw.2026.100788_bib35","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/carcin\/bgt404","article-title":"Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer","volume":"35","author":"Purrington","year":"2014","journal-title":"Carcinogenesis"},{"issue":"10","key":"10.1016\/j.esmorw.2026.100788_bib36","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1200\/JCO.2017.74.8301","article-title":"Tumor PIK3CA genotype and prognosis in early-stage breast cancer: a pooled analysis of individual patient data","volume":"36","author":"Zardavas","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmorw.2026.100788_bib37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10549-018-4661-x","article-title":"Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer","volume":"169","author":"Fostira","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"10.1016\/j.esmorw.2026.100788_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163138","article-title":"Tumor infiltrating lymphocytes affect the outcome of patients with operable triple-negative breast cancer in combination with mutated amino acid classes","volume":"11","author":"Kotoula","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.esmorw.2026.100788_bib39","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1470-2045(10)70130-3","article-title":"Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis","volume":"11","author":"De Roock","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.esmorw.2026.100788_bib40","doi-asserted-by":"crossref","DOI":"10.1200\/CCI-25-00234","article-title":"SNF-CLIMEDIN: a randomized trial of digital support and intervention in patients with advanced non-small cell lung cancer. A Hellenic Cooperative Oncology Group Study","volume":"10","author":"Kosmidis","year":"2026","journal-title":"JCO Clin Cancer Inform"},{"key":"10.1016\/j.esmorw.2026.100788_bib41","article-title":"Comprehensive molecular profiling of advanced NSCLC in Greek patients: a prospective HeCOG study","volume":"48","author":"Kosmidis","year":"2026","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.esmorw.2026.100788_bib42","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.ccell.2026.05.014","article-title":"Spatial biomarker discovery via interpretable semantic learning in histopathology","volume":"44","author":"Liang","year":"2026","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.esmorw.2026.100788_bib43","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/ijc.32651","article-title":"EORTC SPECTA-AYA: a unique molecular profiling platform for adolescents and young adults with cancer in Europe","volume":"147","author":"de Rojas","year":"2020","journal-title":"Int J Cancer"}],"container-title":["ESMO Real World Data and Digital Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949820126001074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949820126001074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:16:19Z","timestamp":1791922579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949820126001074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":43,"alternative-id":["S2949820126001074"],"URL":"https:\/\/doi.org\/10.1016\/j.esmorw.2026.100788","relation":{},"ISSN":["2949-8201"],"issn-type":[{"value":"2949-8201","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HeCOG Cancer Biobank and Registry: a nationwide real-world resource for translational oncology research","name":"articletitle","label":"Article Title"},{"value":"ESMO Real World Data and Digital Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmorw.2026.100788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100788"}}